William Blair Lowers Earnings Estimates for Simulations Plus

Simulations Plus, Inc. (NASDAQ:SLP) – Analysts at William Blair dropped their Q2 2025 earnings per share estimates for Simulations Plus in a report released on Wednesday, January 8th. William Blair analyst M. Smock now anticipates that the technology company will post earnings per share of $0.22 for the quarter, down from their prior estimate of $0.27. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.10 per share. William Blair also issued estimates for Simulations Plus’ Q4 2025 earnings at $0.35 EPS, FY2025 earnings at $1.09 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.43 EPS and FY2026 earnings at $1.35 EPS.

Other analysts have also recently issued reports about the company. Stephens started coverage on Simulations Plus in a report on Friday, November 15th. They set an “overweight” rating and a $39.00 price target on the stock. KeyCorp cut their price objective on Simulations Plus from $40.00 to $35.00 and set an “overweight” rating on the stock in a research note on Wednesday. BTIG Research cut their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, October 24th. Finally, StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $49.00.

Simulations Plus Stock Up 0.1 %

Simulations Plus stock opened at $28.25 on Friday. Simulations Plus has a 12-month low of $24.00 and a 12-month high of $51.22. The business’s 50-day moving average price is $29.82 and its two-hundred day moving average price is $33.72. The stock has a market cap of $567.60 million, a PE ratio of 57.65 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The firm had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. During the same quarter in the previous year, the business posted $0.18 earnings per share. The business’s revenue for the quarter was up 19.9% on a year-over-year basis.

Institutional Investors Weigh In On Simulations Plus

A number of large investors have recently made changes to their positions in SLP. First Horizon Advisors Inc. raised its stake in Simulations Plus by 82.6% during the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after buying an additional 370 shares during the last quarter. nVerses Capital LLC raised its stake in Simulations Plus by 1,100.0% during the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock valued at $38,000 after buying an additional 1,100 shares during the last quarter. Quantbot Technologies LP purchased a new position in Simulations Plus during the third quarter valued at $59,000. Los Angeles Capital Management LLC purchased a new position in Simulations Plus during the second quarter valued at $206,000. Finally, Arizona State Retirement System purchased a new position in Simulations Plus during the second quarter valued at $218,000. 78.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total value of $635,200.00. Following the sale, the director now directly owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 19.40% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.